Pleryon Therapeutics
Pleryon Therapeutics is a preclinical stage biotech startup company. Our mission is to develop novel polymer-based therapeutics to address global unmet medical needs related to aging. Since its formal operation in 2020, Pleryon has raised closed to RMB 100 million from top biotech private investors. Pleryon is advancing its diverse pipelines in multiple disease areas, including ophthalmology, orthopedics, and tissue regeneration.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
6
11 to 50 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Pleryon Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- AL
Andrew Luk
Executive Director, Global Alliance · Other
EmailPhone - YY
Yu Yu
Chief Executive Officer · General Business & Management
EmailPhone
Showing 2 of 4 verified contacts
Top roles at Pleryon Therapeutics
4 distinct titles indexed · top 4 shown.
- 1chief executive officer
- 1chief technology officer
- 1executive director, global alliance
- 1人力资源业务合作伙伴
Sign up to unlock all 4 contacts at Pleryon Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Pleryon Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.